|
EC Continues With ‘Pay-for-Delay’ Crackdown, Charging Servier, Generic Makers
The European Commission (EC) has accused French drugmaker Servier and five generic companies of engaging in anticompetitive “pay-for-delay” agreements, making Servier the second brand drugmaker to take heat from EU regulators over antitrust allegations this month.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives